SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) of the
SECURITIES EXCHANGE ACT OF 1934
__________________
Date of Report (Date of earliest event reported): September 5, 2006
NeoGenomics, Inc.
(Exact Name of Registrant as Specified in Charter)
Nevada |
333-72097 |
74-2897368 |
(State or other jurisdiction |
(Commission |
(IRS Employer |
of incorporation) |
File Number) |
Identification No.) |
12701 Commonwealth Drive, Suite 9, Fort Myers, Florida |
33913 |
(Address of principal executive offices) |
(Zip code) |
|
|
(239) 768-0600 |
|
Registrants telephone number, including area code |
|
|
|
Not Applicable
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ |
] |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ |
] |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ |
] |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ |
] |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
1
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.
On September 5, 2006, Thomas D. Conrad, Ph.D. tendered his resignation as a Director of NeoGenomics, Inc. due to time constraints with his position as President of the General Partner of Competitive Capital Partners, L.P., a Naples, FL based hedge fund.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
NEOGENOMICS, INC. |
|
|
Date: September 8, 2006 |
By: |
|
Name: Robert Gasparini |
|
Its: President |
|
|
|
|